SCHEMBL7997708

SCHEMBL7997708

Cc1c(Cn2cnc3ccccc32)cccc1SCCN1CCN(c2ncccn2)CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.46
CYP11B2 P19099 4/20 0.46
DRD2 P14416 4/20 0.43
DRD3 P35462 4/20 0.43
DRD4 P21917 3/20 0.43
TNF P01375 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
POLB P06746 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
BRD4 O60885 1/20 0.38
HTR1A P08908 1/20 0.38
DRD1 P21728 1/20 0.38
DRD5 P21918 1/20 0.38
HTR2A P28223 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7996230 0.89 CYP11B1 (0.50) CYP11B1CYP11B2DRD2DRD3DRD4
SCHEMBL7998199 0.87 CYP11B1 (0.48) CYP11B1CYP11B2DRD2DRD3DRD4
SCHEMBL7996137 0.81 CYP11B1 (0.54) CYP11B1CYP11B2TNFMEN1KMT2A
SCHEMBL7997671 0.79 CYP11B1 (0.52) CYP11B1CYP11B2TNFMEN1KMT2A
SCHEMBL7994643 0.78 CYP11B1 (0.56) CYP11B1CYP11B2TNFMEN1KMT2A
SCHEMBL7996157 0.77 CYP11B1 (0.52) CYP11B1CYP11B2TNFMEN1KMT2A
SCHEMBL7983622 0.75 CYP11B1 (0.49) CYP11B1CYP11B2TNFMEN1KMT2A
SCHEMBL7996260 0.74 CYP11B1 (0.48) CYP11B1CYP11B2TNFMEN1KMT2A
SCHEMBL8418073 0.73 DRD2 (0.70) DRD2DRD3DRD4ALDH1A1LMNA
SCHEMBL7997859 0.73 CYP11B1 (0.45) CYP11B1CYP11B2TNFMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001034578-A1 COMPOUNDS WITH ANTI-HELICOBACTER PYLORI ACTIVITY ASTRAZENECA AB (SE) 2001-05-17 WO claimed